Prostate cancer kills thousands of Americans each year but new research suggests men can drastically lower their risk ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

For men, a new urine test is improving prostate cancer detection. Men know about the PSA test but there's another test, the "mi-prostate score" or MIPS. It's been available since 2013. It combines PSA ...

A new long-term study published in the New England Journal of Medicine followed 160,000 men for over two decades to examine the real impact of prostate cancer screening. While screening slightly ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being ...